Skip to main content
SpringerLink
Log in

Polyamines and Cancer

  • Chapter
Book cover Polyamine Cell Signaling

Abstract

The polyamines putrescine, spermidine, and spermine are aliphatic cations that play important roles in normal cell proliferation and differentiation and have been shown to be constitutively increased during malignant transformation (1,2). Polyamines are ubiquitous in nature and their cellular levels are intricately regulated by both biosynthetic (ornithine decarboxylase (ODC), S-adenosylmethionine decarboxylase, spermidine synthase, and spermine synthase) and catabolic enzymes (spermidine/spermine acetyl transferase, flavin containing polyamine oxidase, copper containing diamine oxidase, and other amine oxidases) (Fig. 1). Increased levels of polyamines, as observed in human cancers, are the result of deregulation of polyamine metabolism and transport (3,4). Consequently, the polyamine biosynthetic, degradative, and transport pathways have been explored as potential targets for both cancer prevention and therapeutic interventions (5-8). Evidence is presented in this chapter indicating that signaling networks that regulate polyamine levels are possible targets for the design of drugs for human cancer prevention and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gerner, E. W. and Meyskens, F L., Jr. (2004) Polyamines and cancer: Old molecules, new understanding. Nat. Rev. Cancer 4, 781–792.

    Article  PubMed  CAS  Google Scholar 

  2. Wallace, H. M., Fraser, A. V., and Hughes, A. (2003) A perspective of polyamine metabolism. Biochem. J. 376, 1–14.

    Article  PubMed  CAS  Google Scholar 

  3. Thomas, T. and Thomas, T. J. (2003) Polyamine metabolism and cancer. J. Cell Mol. Med. 7, 113–126.

    Article  PubMed  CAS  Google Scholar 

  4. Scalabrino, G. and Ferioli, M. E. (1985) Degree of enhancement of polyamine biosynthetic decarboxylase activities in human tumors: A useful new index of degree of malignancy. Cancer Detect. Prev. 8, 11–16.

    PubMed  CAS  Google Scholar 

  5. Tang, X., Kim, A. L., Feith, D. J., et al. (2004) Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/-mice. J. Clin. Invest. 113, 867–875.

    Article  PubMed  CAS  Google Scholar 

  6. Pegg, A. E., Feith, D. J., Fong, L. Y., Coleman, C. S., O’Brien, T. G., and Shantz, L. M. (2003) Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth. Biochem. Soc. Trans. 31, 356–360.

    Article  PubMed  CAS  Google Scholar 

  7. Coleman, C. S., Pegg, A. E., Megosh, L. C., Guo, Y., Sawicki, J. A., and O’Brien, T. G. (2002) Targeted expression of spermidine/spermine N1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis. Carcinogenesis 23, 359–364.

    Article  PubMed  CAS  Google Scholar 

  8. Feith, D. J., Shantz, L. M., and Pegg, A. E. (2001) Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Cancer Res. 61, 6073–6081.

    PubMed  CAS  Google Scholar 

  9. DiGiovanni, J. (1992) Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54, 63–128.

    Article  PubMed  CAS  Google Scholar 

  10. Yuspa, S. H., Dlugosz, A. A., Denning, M. F., and Glick, A. B. (1996) Multistage carcinogenesis in the skin. J. Invest. Dermatol. Symp. Proc. 1, 147–150.

    CAS  Google Scholar 

  11. Mukhtar, H., Forbes, P. D., and Ananthaswamy, H. N. (1999) Photocarcinogenesis-models and mechanisms. Photodermatol. Photoimmunol. Photomed. 15, 91–95.

    Article  PubMed  CAS  Google Scholar 

  12. de Gruijl, F. R. (1999) Skin cancer and solar UV radiation. Eur J. Cancer 35, 2003–2009.

    Article  PubMed  Google Scholar 

  13. Wheeler, D. L., Martin, K. E., Ness, K. J., et al. (2004) Protein kinase C epsilon is an endogenous photosensitizer that enhance ultraviolet radiation-induce cutaneous damage and development of squamous cell carcinomas. Cancer Res. 64, 7756–7765.

    Article  PubMed  CAS  Google Scholar 

  14. Fujiki, H., Suganuma, M., Sururi, H., et al. (1989) New tumor promoters from marine sources: The okadaic acid class. In: Mycotoxins and Phycotoxins ′88: A Collection of Invited Papers Presented at the Seventh Intern ational IUPAC Symposium on Mycotoxins and P hy c o t oxins, Tokyo, Jap a n, 16-19 August 1988 (Natori, S., Hasimoto, K., and Ueno, Y., eds.), Elsevier, Amsterdam, p. ix.

    Google Scholar 

  15. Arbeit, J. M., Riley, R. R., Huey, B., et al. (1999) Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Cancer Res. 59, 3610–3620.

    PubMed  CAS  Google Scholar 

  16. Gupta, S., Ahmad, N., Marengo, S. R., MacLennan, G. T., Greenberg, N. M., and Mukhtar, H. (2000) Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Cancer Res. 60, 5125–5133.

    PubMed  CAS  Google Scholar 

  17. Lao, C. D., Backoff, P., Shotland, L. I., et al. (2004) Irreversible ototoxicity associated with difluoromethylornithine. Cancer Epidemiol. Biomarkers Prev. 13, 1250–1252.

    PubMed  CAS  Google Scholar 

  18. Verma, A. K. (1990) Inhibition of tumor promotion by DL-alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase. Basic Life Sci. 52, 195–204.

    PubMed  CAS  Google Scholar 

  19. Fischer, S. M., Conti, C. J., Viner, J., Aldaz, C. M., and Lubet, R. A. (2003) Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. Carcinogenesis 24, 945–952.

    Article  PubMed  CAS  Google Scholar 

  20. Wattenberg, L. W., Wiedmann, T. S., and Estensen, R. D. (2004) Chemoprevention of cancer of the upper respiratory tract of the Syrian golden hamster by aerosol administration of difluoromethylornithine and 5-fluorouracil. Cancer Res. 64, 2347–2349.

    Article  PubMed  CAS  Google Scholar 

  21. Alberts, D. S., Dorr, R. T., Einspahr, J. G., et al. (2000) Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol. Biomarke rs Prev. 9, 1281–1286.

    CAS  Google Scholar 

  22. Halmekyto, M., Syrjanen, K., Janne, J., and Alhonen, L. (1992) Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene. Biochem. Biophys Res. Commun. 187, 493–497.

    Article  PubMed  CAS  Google Scholar 

  23. Megosh, L., Gilmour, S. K., Rosson, D., et al. (1995) Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res. 55, 4205–4209.

    PubMed  CAS  Google Scholar 

  24. O’Brien, T. G., Megosh, L. C., Gilliard, G., and Soler, A. P. (1997) Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res. 57, 2630–2637.

    PubMed  CAS  Google Scholar 

  25. Heller, J. S. and Canellakis, E. S. (1981) Cellular control of ornithine decarboxylase activity by its antizyme. J. Cell Physiol. 107, 209–217.

    Article  PubMed  CAS  Google Scholar 

  26. Fong, L. Y., Feith, D. J., and Pegg, A. E. (2003) Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis. Cancer Res. 63, 3945–3954.

    PubMed  CAS  Google Scholar 

  27. Zhang, M., Pickart, C. M., and Coffino, P. (2003) Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate. EMBO J. 22, 1488–1496.

    Article  PubMed  CAS  Google Scholar 

  28. Nilsson, J., Grahn, B., and Heby, O. (2000) Antizyme inhibitor is rapidly induced in growthstimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression. Biochem. J. 346, 699–704.

    Article  PubMed  CAS  Google Scholar 

  29. Pietila, M., Pirinen, E., Keskitalo, S., et al. (2005) Disturbed keratinocyte differentiation in transgenic mice and organotypic keratinocyte cultures as a result of spermidine/spermine N-acetyltransferase overexpression. J. Invest. Dermatol. 124, 596–601.

    Article  PubMed  Google Scholar 

  30. Reddig, P. J., Kim, Y. J., and Verma, A. K. (1996) Localization of the 12-O-tetradecanoylphorbol-13-acetate response of the human ornithine decarboxylase promoter to the TATA box. Mol. Carcinogen 17, 92–104.

    Article  CAS  Google Scholar 

  31. Kennard, M. D., Kang, D. C., Montgomery, R. L., and Butler, A. P. (1995) Expression of epidermal ornithine decarboxylase and nuclear proto-oncogenes in phorbol ester tumor promotion-sensitive and-resistant mice. Mol. Carcinogen 12, 14–22.

    Article  CAS  Google Scholar 

  32. Auvinen, M., Jarvinen, K., Hotti, A., et al. (2003) Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc. Int. J. Biochem. Cell Biol. 35, 496–521.

    Article  PubMed  CAS  Google Scholar 

  33. Jansen, A. P., Dreckschmidt, N. E., Verwiebe, E. G., Wheeler, D. L., Oberley, T. D., and Verma, A. K. (2001) Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C-alpha,-delta and-epsilon transgenic mice. Int. J. Cancer 93, 635–643.

    Article  PubMed  CAS  Google Scholar 

  34. Reddig, P. J., Dreckschmidt, N. E., Ahrens, H., et al. (1999) Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-Otetradecanoylphorbol-13-acetate. Cancer Res. 59, 5710–5718.

    PubMed  CAS  Google Scholar 

  35. Reddig, P. J., Dreckschmidt, N. E., Zou, J., Bourguignon, S. E., Oberley, T. D., and Verma, A. K. (2000) Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res. 60, 595–602.

    PubMed  CAS  Google Scholar 

  36. Mellor, H. and Parker, P. J. (1998) The extended protein kinase C superfamily. Biochem. J. 332, 281–292.

    PubMed  CAS  Google Scholar 

  37. Mochly-Rosen, D. and Kauvar, L. M. (1998) Modulating protein kinase C signal transduction. Adv. Pharmacol. 44, 91–145.

    PubMed  CAS  Google Scholar 

  38. Newton, A. C. (1995) Protein kinase C: Structure, function, and regulation. J. Biol. Chem. 270, 28,495–28,498.

    Article  PubMed  CAS  Google Scholar 

  39. Wang, H. Q., and Smart, R. C. (1999) Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion. J. Cell Sci. 112, 3497–3506.

    PubMed  CAS  Google Scholar 

  40. Jansen, A. P., Verwiebe, E. G., Dreckschmidt, N. E., Wheeler, D. L., Oberley, T. D., and Verma, A. K. (2001) Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res. 61, 808–812.

    PubMed  CAS  Google Scholar 

  41. Tseng, C. P., Kim, Y. J., Kumar, R., and Verma, A. K. (1994) Involvement of protein kinase C in the transcriptional regulation of 12-O-tetradecanoylphorbol-13-acetate-inducible genes modulated by AP-1 or non-AP-1 transacting factors. Carcinogenesis 15, 707–711.

    Article  PubMed  CAS  Google Scholar 

  42. Otieno, M. A. and Kensler, T. W. (2000) A role for protein kinase C-delta in the regulation of ornithine decarboxylase expression by oxidative stress. Cancer Res. 60, 4391–4396.

    PubMed  CAS  Google Scholar 

  43. Verma, A. K. (1989) The enzyme-activated irreversible inhibitor of ornithine decarboxylase, DL-alpha-difluoromethylornithine: A chemopreventive agent. Prev. Med. 18, 646–652.

    Article  PubMed  CAS  Google Scholar 

  44. Pegg, A. E.(1986) Recent advances in the biochemistry of polyamines in eukaryotes. Biochem. J. 234, 249–262.

    PubMed  CAS  Google Scholar 

  45. Igarashi, K. and Kashiwagi, K. (2000) Polyamines: Mysterious modulators of cellular functions. Biochem. Biophys Res. Commun. 271, 559–564.

    Article  PubMed  CAS  Google Scholar 

  46. Wheeler, D. L., Reddig, P. J., Dreckschmidt, N. E., Leitges, M., and Verma, A. K. (2002) Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression. Oncogene 21, 3620–3630.

    Article  PubMed  CAS  Google Scholar 

  47. Wheeler, D. L., Ness, K. J., Oberley, T. D., and Verma, A. K. (2003) Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss. Cancer Res. 63, 3037–3042.

    PubMed  CAS  Google Scholar 

  48. Wheeler, D. L., Ness, K. J., Oberley, T. D., and Verma, A. K. (2003) Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-a l p h a ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice. Cancer Res. 63, 6547–6555.

    PubMed  CAS  Google Scholar 

  49. Baud, V. and Karin, M. (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372–377.

    Article  PubMed  CAS  Google Scholar 

  50. Karin, M., Cao, Y., Greten, F. R., and Li, Z. W. (2002) NF-kappaB in cancer: From innocent bystander to major culprit. Nat. Rev. Cancer 2, 301–310.

    Article  PubMed  CAS  Google Scholar 

  51. Kong Thoo Lin, P., Dance, A. M., Bestwick, C., and Milne, L. (2003) The biological activities of new polyamine derivatives as potential therapeutic agents. B i o chem. Soc. Trans. 31, 407–410.

    CAS  Google Scholar 

  52. Thomas, T., Balabhadrapathruni, S., Gallo, M. A., and Thomas, T. J. (2002) Development of polyamine analogs as cancer therapeutic agents. Oncol. Res. 13, 123–135.

    PubMed  CAS  Google Scholar 

  53. Marton, L. J. and Pegg, A. E. (1995) Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 35, 55–91.

    Article  PubMed  CAS  Google Scholar 

  54. Denstman, S. C., Ervin, S. J., and Casero, R. A., Jr. (1987) Comparison of the effects of treatment with the polyamine analogue N1,N8 bis(ethyl)spermidine (BESpd) or difluoromethylornithine (DFMO) on the Topoisomerase II mediated formation of 4$#xA2:-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) induced cleavable complex in the human lung carcinoma line NCI H157. Biochem. Biophys Res. Commun. 149, 194–202.

    Article  PubMed  CAS  Google Scholar 

  55. Casero, R. A., Jr., Go, B., Theiss, H. W., Smith, J., Baylin, S. B., and Luk, G. D. (1987) Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine. Cancer Res. 47, 3964–3967.

    PubMed  CAS  Google Scholar 

  56. Casero, R. A., Jr., Bergeron, R. J., and Porter, C. W.(1984) Treatment with alpha-difluoromethylornithine plus a spermidine analog leads to spermine depletion and growth inhibition in cultured L1210 leukemia cells. J. Cell Physiol. 121, 476–482.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human Oncology, University of Wisconsin School of Medicine, Madison, WI

    Ajit K. Verma

Authors
  1. Ajit K. Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Surgery and Pathology, University of Maryland School of Medicine and Baltimore Veterans Affairs Medical Center, Baltimore, MD

    Jian-Ying Wang

  2. The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD

    Robert A. Casero Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Verma, A.K. (2006). Polyamines and Cancer. In: Wang, JY., Casero, R.A. (eds) Polyamine Cell Signaling. Humana Press. https://doi.org/10.1007/978-1-59745-145-1_18

Download citation

Publish with us

Policies and ethics

Search

Navigation